Gadolinium-based Contrast Agent Global Analysis & Forecast to 2024 Gadolinium-based Contrast Agent Market - Global In | Page 2

others. The cardiovascular disorders segment accounted for a large share of the
global market and the trend is expected to continue during the forecast period.
Advancements in cardiac MRI procedures in catheterization labs and promising
reimbursement scenario for contrast agent products used during cardiovascular
diagnosis along with highly developed health care infrastructure in countries such
as Germany, the U.K., the U.S., and Canada are factors fueling the growth of the
cardiovascular disorders segment. According to a survey of the Centers for Disease
Control and Prevention, every year about 735,000 people have a heart attack in the
U.S. Out of this number, 525,000 are the first heart attacks and 210,000 happen in
people who have already suffered a heart attack. In addition, growth of the segment
is attributed to the rise in number of diagnostic procedures coupled with the
increase in disease burden in developing countries. In terms of end-user, the market
is segmented into hospitals, specialty clinics, diagnostic centers, and others.
Geographically, the global gadolinium-based contrast agent market is distributed
over North America (the U.S. and Canada), Europe (Germany, France, the U.K., and
others), Asia Pacific (Australia, China, Japan, India, and others), Latin America, and
Middle East & Africa. North America dominated the market in terms of revenue.
North America was followed by Europe and is expected to register a high growth of
the market. Emerging markets such as Asia Pacific, Latin America, and Middle East
& Africa are expected to record a robust growth during the forecast period owing to
growing health care industry and aging population, which consequently are
projected to result in the increase of patient population. India, China, and Brazil are
likely to drive a significant growth of the market among the emerging countries
owing to increase in investments by government bodies in order to enhance health
care facilities.
Major players operating in this market are GE Healthcare, Bayer HealthCare,
Guerbet, Bracco Diagnostic Inc., and Lantheus Medical Imaging, Inc.
The report offers a comprehensive evaluation of the market. It does so via in-depth
qualitative insights, historical data, and verifiable projections about market size. The
projections featured in the report have been derived using proven research
methodologies and assumptions. By doing so, the research report serves as a
repository of analysis and information for every facet of the market, including but
not limited to: Regional markets, technology, types, and applications.
Get accurate market forecast and analysis on the Gadolinium-based
Contrast Agent market. Request a sample to stay abreast on the key
trends impacting this market.
http://www.transparencymarketresearch.com/sample/sample.php?
flag=B&rep_id=22862
The study is a source of reliable data on:
Market segments and sub-segments